Biotricity Inc
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux and Biocore Pro, an integrated ECG device and software that utilizes … Read more
Biotricity Inc (BTCY) - Total Assets
Latest total assets as of September 2025: $6.32 Million USD
Based on the latest financial reports, Biotricity Inc (BTCY) holds total assets worth $6.32 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Biotricity Inc - Total Assets Trend (2014–2025)
This chart illustrates how Biotricity Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Biotricity Inc - Asset Composition Analysis
Current Asset Composition (March 2025)
Biotricity Inc's total assets of $6.32 Million consist of 82.2% current assets and 17.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 6.5% |
| Accounts Receivable | $2.72 Million | 48.2% |
| Inventory | $1.56 Million | 27.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2014–2025)
This chart illustrates how Biotricity Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Biotricity Inc's current assets represent 82.2% of total assets in 2025, a decrease from 100.0% in 2014.
- Cash Position: Cash and equivalents constituted 6.5% of total assets in 2025, down from 86.5% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 48.2% of total assets.
Biotricity Inc Competitors by Total Assets
Key competitors of Biotricity Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Biotricity Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Biotricity Inc generates 2.44x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Biotricity Inc is currently not profitable relative to its asset base.
Biotricity Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.23 | 0.19 | 0.59 |
| Quick Ratio | 0.14 | 0.10 | 0.57 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-18.08 Million | $ -17.42 Million | $ -3.50 Million |
Biotricity Inc - Advanced Valuation Insights
This section examines the relationship between Biotricity Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 33.02 |
| Latest Market Cap to Assets Ratio | 0.62 |
| Asset Growth Rate (YoY) | -5.1% |
| Total Assets | $5.64 Million |
| Market Capitalization | $3.50 Million USD |
Valuation Analysis
Below Book Valuation: The market values Biotricity Inc's assets below their book value (0.62 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Biotricity Inc's assets decreased by 5.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Biotricity Inc (2014–2025)
The table below shows the annual total assets of Biotricity Inc from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | $5.64 Million | -5.08% |
| 2024-03-31 | $5.94 Million | -8.72% |
| 2023-03-31 | $6.51 Million | -60.96% |
| 2022-03-31 | $16.68 Million | +275.80% |
| 2021-03-31 | $4.44 Million | +121.41% |
| 2020-03-31 | $2.00 Million | +308.51% |
| 2019-03-31 | $490.66K | -47.21% |
| 2018-03-31 | $929.43K | +96.28% |
| 2017-03-31 | $473.51K | -8.78% |
| 2016-03-31 | $519.09K | -0.17% |
| 2015-03-31 | $520.00K | 0.00% |
| 2014-03-31 | $520.00K | -- |